BCAX
Price
$28.99
Change
-$1.41 (-4.64%)
Updated
Jul 8 closing price
Capitalization
2B
40 days until earnings call
Intraday BUY SELL Signals
JAZZ
Price
$248.25
Change
+$0.53 (+0.21%)
Updated
Jul 8 closing price
Capitalization
15.56B
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs JAZZ

BCAX vs JAZZ Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BCAX vs. JAZZ commentary
Jul 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a Buy and JAZZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2026
Stock price -- (BCAX: $29.22 vs. JAZZ: $244.17)
Brand notoriety: BCAX and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 44% vs. JAZZ: 55%
Market capitalization -- BCAX: $2B vs. JAZZ: $15.56B
BCAX [@Biotechnology] is valued at $2B. JAZZ’s [@Biotechnology] market capitalization is $15.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $132.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 1 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 1 green, 4 red.
According to our system of comparison, BCAX is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 6 TA indicator(s) are bullish while JAZZ’s TA Score has 3 bullish TA indicator(s).

  • BCAX’s TA Score: 6 bullish, 3 bearish.
  • JAZZ’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BCAX is a better buy in the short-term than JAZZ.

Price Growth

BCAX (@Biotechnology) experienced а -1.58% price change this week, while JAZZ (@Biotechnology) price change was +1.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.92%. For the same industry, the average monthly price growth was +13.38%, and the average quarterly price growth was +2000.21%.

Reported Earning Dates

BCAX is expected to report earnings on Aug 18, 2026.

JAZZ is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (+1.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($15.6B) has a higher market cap than BCAX($2B). JAZZ has higher P/E ratio than BCAX: JAZZ (2256.82) vs BCAX (3.41). BCAX YTD gains are higher at: 80.630 vs. JAZZ (45.718). JAZZ has higher annual earnings (EBITDA): 675M vs. BCAX (-173.93M). JAZZ has more cash in the bank: 2.87B vs. BCAX (540M). BCAX has less debt than JAZZ: BCAX (1.44M) vs JAZZ (5.42B). JAZZ has higher revenues than BCAX: JAZZ (4.44B) vs BCAX (0).
BCAXJAZZBCAX / JAZZ
Capitalization2B15.6B13%
EBITDA-173.93M675M-26%
Gain YTD80.63045.718176%
P/E Ratio3.412256.820%
Revenue04.44B-
Total Cash540M2.87B19%
Total Debt1.44M5.42B0%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
43

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCAXJAZZ
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 1 day ago
66%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 16 days ago
58%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 1 day ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
JAZZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DCMT32.280.60
+1.90%
DoubleLine Commodity Strategy ETF
XQQI50.570.88
+1.77%
NEOS Boosted Nasdaq-100 High Income ETF
INFL50.100.02
+0.04%
Horizon Kinetics Inflation Bnfcrs ETF
CSB66.10N/A
N/A
VictoryShares US SmCp Hi Div Vol Wtd ETF
MULL35.26N/A
N/A
GraniteShares 2x Long MU Daily ETF

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with CLDX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
N/A
CLDX - BCAX
48%
Loosely correlated
N/A
PCVX - BCAX
47%
Loosely correlated
N/A
RCUS - BCAX
44%
Loosely correlated
+0.03%
BCYC - BCAX
44%
Loosely correlated
N/A
ARVN - BCAX
43%
Loosely correlated
N/A
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with ZYME. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
N/A
ZYME - JAZZ
49%
Loosely correlated
N/A
AMLX - JAZZ
43%
Loosely correlated
N/A
CLDX - JAZZ
39%
Loosely correlated
N/A
ANVS - JAZZ
35%
Loosely correlated
+3.65%
BCAX - JAZZ
34%
Loosely correlated
N/A
More